{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:30:57Z","timestamp":1793633457977,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000858","name":"University of Sheffield","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"United Kingdom Department of Health & Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103089","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:45:37Z","timestamp":1788479137000},"page":"103089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2592-116X","authenticated-orcid":false,"given":"Adithya","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5293-0413","authenticated-orcid":false,"given":"Jixin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-9946","authenticated-orcid":false,"given":"Manoj","family":"Pohare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-8177","authenticated-orcid":false,"given":"Thomas C.","family":"Minshull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia M.","family":"Slowik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8294-1264","authenticated-orcid":false,"given":"Kate A.","family":"Loveday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9105-7079","authenticated-orcid":false,"given":"Zoe V.R.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabrouka","family":"Maamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Colley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Murdoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6598-8369","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Kis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103089_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtn.2026.103089_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.628137","article-title":"The limitless future of RNA therapeutics","volume":"9","author":"Damase","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103089_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.103089_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2017.11.034","article-title":"Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine","volume":"156","author":"Kwon","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2026.103089_bib5","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic mRNA applications","volume":"33","author":"\u017bak","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103089_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trsl.2021.11.009","article-title":"Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials","volume":"242","author":"Whitley","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.omtn.2026.103089_bib7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.tibtech.2022.03.012","article-title":"Quality by Design for enabling RNA platform production processes","volume":"40","author":"Daniel","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omtn.2026.103089_bib8","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: Platforms and current developments","volume":"30","author":"Szab\u00f3","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103089_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-0716-3770-8_16","article-title":"Quality by Digital Design for developing platform RNA vaccine and therapeutic manufacturing processes","volume":"2786","author":"Nair","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103089_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67797-x","article-title":"COMPARING vaccine manufacturing technologies recombinant DNA vs in vitro transcribed (IVT) mRNA","volume":"14","author":"Davidopoulou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103089_bib11","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: Challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2026.103089_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-59745-248-9_3","article-title":"Synthesis of RNA by in vitro transcription","volume":"703","author":"Beckert","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103089_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-62703-260-5_2","article-title":"In vitro transcription of long RNA containing modified nucleosides","volume":"969","author":"Pardi","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103089_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0076-6879(89)80091-6","article-title":"[5] Synthesis of small RNAs using T7 RNA polymerase","volume":"180","author":"Milligan","year":"1989","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtn.2026.103089_bib15","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1002\/cpz1.39","article-title":"Cap 1 messenger RNA synthesis with co-transcriptional CleanCap\u00ae analog by in vitro transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.omtn.2026.103089_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103089_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103089_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-022-00447-3","article-title":"Pandemic-response adenoviral vector and RNA vaccine manufacturing","volume":"7","author":"Kis","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2026.103089_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/vaccines9010003","article-title":"Resources, production scales and time required for producing RNA vaccines for the global pandemic demand","volume":"9","author":"Kis","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2026.103089_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2025.134837","article-title":"Continuous purification of mRNA by precipitation and sequential TFF","volume":"379","author":"Pons Royo","year":"2025","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.omtn.2026.103089_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400473","article-title":"An experimental and modeling approach to study tangential flow filtration performance for mRNA drug substance purification","volume":"19","author":"Nourafkan","year":"2024","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2026.103089_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2025.123730","article-title":"Single-pass tangential flow filtration (SPTFF) for continuous mRNA concentration and purification","volume":"719","author":"Javidanbardan","year":"2025","journal-title":"J. Memb. Sci."},{"key":"10.1016\/j.omtn.2026.103089_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103089_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102491","article-title":"Reverse-phase chromatography removes double-stranded RNA, fragments, and residual template to decrease immunogenicity and increase cell potency of mRNA and saRNA","volume":"36","author":"Kru\u0161i\u010d","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103089_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-62703-260-5_3","article-title":"HPLC purification of in vitro transcribed long RNA","volume":"969","author":"Weissman","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103089_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102549","article-title":"Removal of dsRNA byproducts using affinity chromatography","volume":"36","author":"Clark","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103089_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102333","article-title":"Quality by design for mRNA platform purification based on continuous oligo-dT chromatography","volume":"35","author":"Qu","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103089_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2022.122320","article-title":"Development and scale-up of oligo-dT monolithic chromatographic column for mRNA capture through understanding of base-pairing interactions","volume":"304","author":"Mencin","year":"2023","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.omtn.2026.103089_bib29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.18609\/cgti.2021.161","article-title":"Chromatographic purification with CIMmultus\u2122 Oligo dT increases mRNA stability","volume":"7","author":"Koren\u010d","year":"2021","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omtn.2026.103089_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464670","article-title":"Improved mRNA affinity chromatography binding capacity and throughput using an oligo-dT immobilized electrospun polymer nanofiber adsorbent","volume":"1717","author":"Dewar","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.omtn.2026.103089_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100999","article-title":"High-salt transcription of DNA cotethered with T7 RNA polymerase to beads generates increased yields of highly pure RNA","volume":"297","author":"Cavac","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.103089_bib32","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1093\/nar\/15.21.8783","article-title":"Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates","volume":"15","author":"Milligan","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103089_bib33","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/bit.28216","article-title":"Maximizing mRNA vaccine production with Bayesian optimization","volume":"119","author":"Rosa","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtn.2026.103089_bib34","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cite.202200133","article-title":"Gram-scale mRNA production using a 250-mL single-use bioreactor","volume":"94","author":"Skok","year":"2022","journal-title":"Chem. Ing. Tech."},{"key":"10.1016\/j.omtn.2026.103089_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2024.109412","article-title":"Maximizing the mRNA productivity for in vitro transcription by optimization of fed-batch strategy","volume":"210","author":"Guo","year":"2024","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.omtn.2026.103089_bib36","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1002\/bit.28806","article-title":"Quality by design approach to improve quality and decrease cost of in vitro transcription of mRNA using design of experiments","volume":"121","author":"Boman","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtn.2026.103089_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41587-022-01525-6","article-title":"An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts","volume":"41","author":"Dousis","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103089_bib38","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1093\/nar\/gkt1193","article-title":"Syn5 RNA polymerase synthesizes precise run-off RNA products","volume":"42","author":"Zhu","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103089_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1039\/D4FD00023D","article-title":"An engineered T7 RNA polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis","volume":"252","author":"Miller","year":"2024","journal-title":"Faraday Discuss."},{"key":"10.1016\/j.omtn.2026.103089_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1504876","article-title":"Bacteriophage RNA polymerases: catalysts for mRNA vaccines and therapeutics","volume":"11","author":"Nair","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtn.2026.103089_bib41","article-title":"Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein","author":"Chan","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2026.103089_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/acssynbio.2c00609","article-title":"Low resource integrated platform for production and analysis of capped mRNA","volume":"12","author":"Nwokeoji","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.omtn.2026.103089_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.mie.2023.06.001","article-title":"A simple approach to improving RNA synthesis: Salt inhibition of RNA rebinding coupled with strengthening promoter binding by a targeted gap in the DNA","volume":"691","author":"Malagoda Pathiranage","year":"2023","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtn.2026.103089_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1426129","article-title":"Understanding the impact of in vitro transcription byproducts and contaminants","volume":"11","author":"Lenk","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtn.2026.103089_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz700","article-title":"Efficient inhibition of RNA self-primed extension by addition of competing 3\u2032-capture DNA-improved RNA synthesis by T7 RNA polymerase","volume":"47","author":"Gholamalipour","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103089_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.omtn.2022.08.001","article-title":"Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA","volume":"29","author":"Piao","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103089_bib47","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1021\/bi00188a022","article-title":"Effects of solution conditions on the steady-state kinetics of initiation of transcription by T7 RNA polymerase","volume":"33","author":"Maslak","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2026.103089_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad027","article-title":"High-salt transcription from enzymatically gapped promoters nets higher yields and purity of transcribed RNAs","volume":"51","author":"MalagodaPathiranage","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103089_bib49","series-title":"Device for continuously producing and analyzing RNA","author":"Liao","year":"2023"},{"key":"10.1016\/j.omtn.2026.103089_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpj.2011.12.014","article-title":"A multiphysics model of in vitro transcription coupling enzymatic reaction and precipitation formation","volume":"102","author":"Akama","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.omtn.2026.103089_bib51","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1007\/s00216-026-06542-x","article-title":"High-throughput monitoring of free Mg2+ in IVT reaction reveals effects of free Mg2+ on mRNA synthesis and DNA digestion","volume":"418","author":"Maru\u0161i\u010d","year":"2026","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.omtn.2026.103089_bib52","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/elps.202400044","article-title":"Detection of residual T7 RNA polymerase used in mRNA in vitro transcription by Simple Western","volume":"45","author":"Shieh","year":"2024","journal-title":"Electrophoresis"},{"key":"10.1016\/j.omtn.2026.103089_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1250833","article-title":"Anion exchange HPLC monitoring of mRNA in vitro transcription reactions to support mRNA manufacturing process development","volume":"11","author":"Welbourne","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtn.2026.103089_bib54","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1039\/D5AN00033E","article-title":"Mass spectrometry-based mRNA sequence mapping via complementary RNase digests and bespoke visualisation tools","volume":"150","author":"Welbourne","year":"2025","journal-title":"Analyst"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600260X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600260X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:11:39Z","timestamp":1793632299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312600260X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S216225312600260X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103089","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103089"}}